Post Marketing Surveillance of Remicade
NCT00724529
·
clinicaltrials.gov ↗
COMPLETED
Status
938
Enrollment
INDUSTRY
Sponsor class
Conditions
Crohn's Disease
Ankylosing Spondylitis
Interventions
BIOLOGICAL:
Infliximab
Sponsor
Janssen Korea, Ltd., Korea